Skip to main content
. 2022 Sep 15;15:5361–5371. doi: 10.2147/JIR.S377767

Table 3.

Multivariable Logistic Regression Analysis for the sUAR as Categorical Variable

Variables PC-AKI In-Hospital MACEs
OR 95% CI P value OR 95% CI P value
Q1 Reference Reference
Q2 1.18 0.69~2.01 0.541 0.70 0.42~1.14 0.150
Q3 1.85 1.12~3.06 0.016 0.86 0.54~1.39 0.546
eGFR 0.98 0.98~0.99 <0.001 0.98 0.98~0.99 0.000
Age 1.03 1.02~1.05 <0.001 1.02 1.00~1.04 0.035
Female 0.69 0.45~1.08 0.104 1.20 0.77~1.89 0.417
Killip classification 1.93 1.36~2.73 <0.001 2.67 1.84~3.86 <0.001
Anemia 1.05 0.74~1.48 0.800 0.88 0.61~1.28 0.504
Current smoking 0.87 0.59~1.28 0.482 1.12 0.75~1.67 0.595
Diabetes 1.61 1.14~2.27 0.007 1.05 0.72~1.52 0.817
Hypertension 0.93 0.66~1.33 0.708 0.86 0.60~1.24 0.413
COPD 0.71 0.30~1.69 0.444 1.19 0.52~2.72 0.684
Previous MI 0.49 0.30~0.78 0.003 0.73 0.46~1.16 0.179
Prior PCI 0.80 0.49~1.31 0.373 0.76 0.44~1.30 0.311
Prior stroke 1.88 1.21~2.95 0.005 1.61 0.99~2.64 0.056
Aspirin 0.81 0.26~2.51 0.718 0.51 0.18~1.44 0.204
GP IIb/IIIa inhibitor 1.00 0.70~1.42 0.990 1.55 1.08~2.22 0.017
Multi-vessel stenosis 1.08 0.76~1.55 0.658 1.47 0.98~2.20 0.059
PCI access 1.43 0.98~2.09 0.066 2.19 1.50~3.20 <0.001

Abbreviations: eGFR, estimated glomerular filtration rate; COPD, chronic obstructive pulmonary disease; MI, myocardial infarction; PCI, percutaneous coronary intervention.